VBCG
BMY icon

Valley Brook Capital Group’s Bristol-Myers Squibb BMY Stock Holding History

Valley Brook Capital Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$390K Hold
6,770
– – 0.22% 82
2026
Q1 		$411K Hold
6,770
– – 0.28% 76
2025
Q4 		$365K Hold
6,770
– – 0.24% 84
2025
Q3 		$305K Sell
6,770
-50
-0.7% -$2.33K 0.21% 91
2025
Q2 		$316K Hold
6,820
– – 0.24% 88
2025
Q1 		$416K Sell
6,820
-500
-7% -$29.1K 0.33% 67
2024
Q4 		$414K Sell
7,320
-150
-2% -$8.38K 0.31% 72
2024
Q3 		$386K Sell
7,470
-875
-10% -$41K 0.28% 80
2024
Q2 		$347K Sell
8,345
-1,000
-11% -$44.7K 0.27% 84
2024
Q1 		$507K Sell
9,345
-2,230
-19% -$114K 0.41% 59
2023
Q4 		$594K Sell
11,575
-200
-2% -$10.5K 0.52% 54
2023
Q3 		$683K Hold
11,775
– – 0.68% 49
2023
Q2 		$753K Sell
11,775
-300
-2% -$20.1K 0.7% 46
2023
Q1 		$837K Buy
12,075
+45
+0.4% +$3.17K 0.77% 41
2022
Q4 		$866K Hold
12,030
– – 0.83% 36
2022
Q3 		$855K Hold
12,030
– – 0.93% 35
2022
Q2 		$926K Hold
12,030
– – 0.95% 32
2022
Q1 		$878K Buy
12,030
+116
+1% +$7.79K 0.76% 42
2021
Q4 		$742K Sell
11,914
-100
-0.8% -$5.87K 0.64% 47
2021
Q3 		$710K Buy
12,014
+5,070
+73% +$334K 0.7% 45
2021
Q2 		$463K Buy
6,944
+235
+4% +$15.3K 0.44% 62
2021
Q1 		$423K Buy
6,709
+81
+1% +$5.04K 0.38% 61
2020
Q4 		$411K Buy
+6,628
New +$408K 0.41% 58

Other funds holding BMY

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Valley Brook Capital Group's BMY Position: Q2 2026 in Review

Valley Brook Capital Group held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 6,770 shares worth $390K. The position accounts for 0.22% of the portfolio, ranked #82.

Valley Brook Capital Group first reported a position in BMY in Q4 2020 and has held it in 23 quarters since. The position peaked at $926K in Q2 2022. 1,487 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Valley Brook Capital Group held 6,770 shares of Bristol-Myers Squibb worth $390K as of Q2 2026.
  • Valley Brook Capital Group left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.22% of Valley Brook Capital Group's portfolio in Q2 2026, its #82 holding.
  • Valley Brook Capital Group first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 23 quarters since.
  • Valley Brook Capital Group's Bristol-Myers Squibb position peaked at $926K in Q2 2022.
  • 1,487 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Valley Brook Capital Group's 13F filing for Q2 2026, filed 27 Jul 2026.